chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received on 24-APR-2017 from a female pharmacy technician, referring to one unspecified patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug allergies were not reported. The pharmacy technician reported that on 21-APR-2017, an unspecified patient was vaccinated with improperly stored ZOSTAVAX (Lot number M036296, expiration date 14-NOV-2017) reconstituted with properly stored DILUENT MRK (Lot number reported as L032214 (as reported), expiration date 13-APR-2018) for prophylaxis. The Dose, strength, site of administration and route of administration of ZOSTAVAX was not reported. The ZOSTAVAX excursion information was reported as: exposed to temperature: 8.2 F (8.2 degrees Fahrenheit) for a time frame of 1 hours 15 minutes. There was a previous temperature excursion reported (date not specified): 6F to 14F (6 degrees Fahrenheit to 14 degrees Fahrenheit) for 2 hours. The call was because of a data logger. No adverse effect reported. There was no product quality complaint involved. No further information was provided. This is one of two reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA012523.
Detached Retina Right Eye, Blood Clot left arm, loss of vision in the top of my right eye
I have been having severe hot flash like feeling.  Feel like I have a fever.  I check my temp and it is usually 97.0 - 99.0.  I have been taking Tylenol 1000mg 1 x a day and Naproxen 220mg 2 tabs 1 x a day to help with the discomfort.   My skin feels hot from my neck down to my hips.  I have occasional body aches.  My arm was very sore the day after the injection.  The 2nd day after it started feeling better than by the30th my arm was fine.  I am getting Covid tested weekly at my work and all have been negative so far.  I am getting tested tonight and will let you know what the results are.
Patient recieved vaccines at 11:05 AM. Patient was asked to remain in exam room with father for 15 minutes post vaccination. At about 11:10 AM patients father reported to nurses that patient had started vomiting. Patient was asked to sit in chair and was given a cool cloth for comfort. Dr. was made aware and she examined the patient. Patient stated she "felt fine" at 11:20 AM and left the clinic at 11:25 AM in stable condition accompanied by her father.
Two days after dt administration. He developed soreness, redness of arm.  Had fever to 103 and felt weak and lightheaded on 2/3/06. Arm still sore on 2/6/06-14x24cm area of erythema on exam of right upper arm.  Treatment-Predinose and Benadryl
Left arm started to have sharp pain, pain travelled down to elbow. Hands are numb, fingers were tingly. Was prescribed medications and the medications did not work.
anxiety attack; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer-sponsored program Pfizer First Connect. This female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient's medical history included dental work done from an unknown date and unknown if ongoing. Concomitant mediations were not reported. The patient reported that she had the COVID vaccine and dental work done, inquired if that was okay; while asking, the patient mentioned she didn't want to answer questions due to having an anxiety attack. The clinical outcome of anxiety attack was unknown.  No follow-up attempts are possible. Information on Lot/batch number cannot be obtained.
Information has been received from a female who was vaccinated with Zostavax (Oka/Merck). A few week later the patient experienced "electrical shock" in her right eye and she had pustules on her right eyebrow down to her eyelids. The patient went to a specialist and was prescribed valacyclovir (Valtrex) for 7 days. The patient's electrical shock in her right eye and pustules on her right eyebrow persisted. No further information is available.
Vaccine 12/25, 1/19.  admitted 2/18, tested COVID+ with PNA. Treated w/abx, dexa and convalescent plasma. DCd back to NH.
Participant felt very cold and tired. Felt a bad cold. Tested positive for COVID-19 on 4/15/2022. Tested at an Urgent Care.
Increased fluid in left eye with significant decreased vision started 1 week post immunization; and shingles started 1/29/2021
Patient positive for COVID-19 on 2/24/21 after completing vaccination. She had shortness of breath but no other symptoms at that time.
Lost smell; Lost taste; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old non pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via unspecified route in the left arm on 06Mar2021 at 05:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Mar2021 at 15:00 the day after the first dose, the patient lost her smell and taste for approximately 24 hours. The patient did not receive any treatment for the adverse events. The clinical outcome of events lost smell and lost taste was resolved as on 08Mar2021.   Information about lot number cannot be obtained. No further information is expected.
Fever; chills; aches; armpits swelled; metal mouth tast; high blood pressure; Nausea; Ringing in ears; migraine; Chemical burn; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via an unspecified route of administration in the left arm on 06Mar2021 at 14.30 (at the age of 36 years old) as dose 2, single for COVID-19 immunisation. The patient's medical history included fibromyalgia and asthma. The Patient did not have any allergies to medications, food, or other products. Prior to the COVID vaccination, the patient had not received any other vaccines within 4 weeks and no medication within two weeks and had not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via an unspecified route of administration on unknown date as single dose for COVID-19 immunisation and experienced giant red rash. On 06Mar2021 at 16:00, the patient experienced fever, chills, aches, armpit swelling, metallic taste in mouth, migraine, high blood pressure, nausea, ringing in ears and chemical burn during a hair dye process. The patient underwent lab tests and procedures, which included COVID-19 Virus test ( nasal swab test) on 09Mar2021 and showed negative. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 18-JUL-2016, the patient was vaccinated with improperly stored dose of RECOMBIVAX HB lot # M000442, expiration date 31-MAR-2018 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt had a strange feeling in head for the past year. Best way to describe it pt felt like pt was under water; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "Pt had a strange feeling in head for the past year. Best way to describe it pt felt like pt was under water"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization, reaction(s): "Pt had a strange feeling in head for the past year. Best way to describe it pt felt like pt was under water". The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Pt had a strange feeling in head for the past year. Best way to describe it pt felt like pt was under water".  Additional information: Pt received all 3 pfizer vaccines. Pt had a strange feeling in head for the past year. Best way to describe it was pt felt like pt was under water. Been to several doctors and could not explain why or gave pt a remedy. There were a lot of people online that had the same symptoms. All had their shots, all seem to thought like pt do that was the result of the vaccine. Pt know that there had not been enough studies, but with people being concerned that the probability of this feeling could be the result.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
rash on arm/arm rash; vaginal itching; intense anal itching; fatigue; tenderness; This non-serious case was reported by a consumer via call center representative and described the occurrence of rash in a adult female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   The patient's past medical history included hemorrhoids.   On 22-SEP-2023, the patient received Arexvy (unknown arm). On 23-SEP-2023, 1 days after receiving Arexvy, the patient experienced rash (Verbatim: rash on arm/arm rash), vaginal itching (Verbatim: vaginal itching), anal pruritus (Verbatim: intense anal itching), fatigue (Verbatim: fatigue) and tenderness (Verbatim: tenderness).  On 23-SEP-2023, the outcome of the fatigue was resolved. The outcome of the rash, vaginal itching, anal pruritus and tenderness were not resolved.   It was unknown if the reporter considered the rash, vaginal itching, anal pruritus, fatigue and tenderness to be related to Arexvy.     It was unknown if the company considered the rash, vaginal itching, anal pruritus, fatigue and tenderness to be related to Arexvy.   Additional Information: GSK receipt date: 28-SEP-2023 The following day of vaccination, patient experienced rash on arm, tenderness, and fatigue.   The fatigue resolved the same day, arm rash and tenderness were still ongoing.   The patient also started experiencing intense anal and vaginal itching, which remained ongoing.   She declined to provide any further details. The reporter asked for permission to follow-up but she declined to answer. The reporter did not consent to follow-up.
Redness, swelling, induration of site, continued expansion despite antibiotics, fever and chills and generalized weakness.
After administration patient waited her 15 minutes in waiting area then on her way out the door noticed her neck rash and had itching. Pt came back to us where we could monitor her. She had no issues breathing but noticed some tightness developing in her mouth. I administered 1ml diphenhydramine 50mg IM x1 in her right deltoid.  After waiting 15 minutes she stated she felt much better and was able to return home.
Covid positive; sore neck; sore tongue; feel sick; Some low fever also (99.5°F); This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Covid positive), NECK PAIN (sore neck), GLOSSODYNIA (sore tongue), MALAISE (feel sick) and PYREXIA (Some low fever also (99.5°F)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 01-Mar-2021, the patient experienced NECK PAIN (sore neck), GLOSSODYNIA (sore tongue), MALAISE (feel sick) and PYREXIA (Some low fever also (99.5°F)). On 04-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid positive). At the time of the report, SARS-COV-2 TEST POSITIVE (Covid positive), NECK PAIN (sore neck), GLOSSODYNIA (sore tongue), MALAISE (feel sick) and PYREXIA (Some low fever also (99.5°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, COVID-19: Positive.         No Concomitant medications were provided. No Treatment History was provided.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 31-JAN-2017, the patient was vaccinated with incorrectly stored dose of M-M-R II, lot # L049314, expiry date 03-DEC-2017 (dose, route and site of administration were not reported). Administered vaccine experienced the temperature excursion of -14.4 Celsius degrees for 54 minutes. There was no previous temperature excursion reported. Data logger was involved. No adverse effects reported. This is one of several cases received from the same reporter. Additional information is not expected, all information has already been obtained.; Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:
This spontaneous report was received from a female medical assistant of unknown age, via a company representative, referring to herself. Patient's medical history and concurrent conditions were not reported. On an unknown date, the patient cut her finger while administering a dose of RECOMNIVAX HB (strength, dose, frequency, route, lot # and expiration date were not reported). The reporter stated that the prefilled syringe broke during the attempt. No concomitant therapies were reported. A product quality complaint was reported. Additional information has been requested.
I received my 2nd dose of the Moderna Vaccine on Wednesday the 27th of January.  Immediately I felt soreness in my arm. About three hours later I began to feel light headed and fatigued. Over night between the 27th and 28th I became feverish, with chills, shaking, and sweating. On the 28th I experienced fatigue, lymph node swelling in my neck and left armpit, and all over body aches. On the 29th I continued to experience fatigue and pain in my lymph nodes. In addition, I began to experience a migraine headache which  persisted for about 30 hours. My symptoms generally abated  by the morning of the 31st .
Received vax about 2 PM 12-7-00. AT about 8 PM, she had shortness of breath. At 9:30 chills, and then rapid heart beat. Ears were also hurting. Has head congestion today. Right eye is red.
RECEIVED AN EXPIRED DOSE OF THE VACCINE; This spontaneous report received from a health care professional concerned a 60 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 207A21A, and batch number: 207A21A expiry: 26-JUN-2021) dose was not reported, administered on 24-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-MAY-2021, the subject experienced received an expired dose of the vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of received an expired dose of the vaccine was not reported. This report was non-serious.
Nausea; low fever; body aches; eye irritation; chills; headache; Nausea, low fever, body aches, eye irritation, chills, headache and fatigue; This is a spontaneous report from a non-contactable consumer reported for herself. A 72-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: EN6204), dose 2 via an unspecified route of administration, administered in left arm on 06Mar2021 at 10:45 (at the age of 72-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included osteoarthritis (inflammatory osteoarthritis), hypertension (HBP) and hiatus hernia from an unknown date and unknown if ongoing. Drug hypersensitivity (known allergies: PCN) to penicillin from an unknown date and unknown if ongoing. Concomitant medication was not reported. Patient was not pregnant at the time of vaccination. Historical vaccine included: BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: EL9267) as dose 1, single administered in right arm on 03Feb2021 at 10:45 AM for COVID-19 immunization. No other vaccine in four weeks. No COVID prior vaccination. On 06Mar2021 at 16:45, the patient experienced nausea, low fever, body aches, eye irritation, chills, headache, and fatigue. No treatment received for adverse event. No COVID tested post vaccination. The outcome of the events were recovered on 2021.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a healthcare worker, and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On 09-MAY-2016, the patient was vaccinated with an expired dose of VAQTA (which had a lot number of K001296 and an expiration date of 15-JAN-2016; however, dose, dosage number, route of administration and anatomical location were not reported). No concomitant medications were reported. Despite being vaccinated with an expired dose of the vaccine, no adverse effects were reported and no product quality complaint was involved. Additional information has been requested.
injection site pain (roughly 30 minutes after and progressed to arm soreness later in the day that lasted about 2 weeks) dizziness (about 30 min after, lasted about 15 minutes) severe abdominal pain, lethargy, body aches, fatigue starting about 30 hours after injection, lasted 18-24 hours). Abdominal pain felt similar to previous flare of diverticulitis. ibuprofen, sleep, and low fiber foods helped redness and swelling at the injection site (started within an 2 hours) severe itching, redness, and swelling started about 1 week after injection and spread around arm, roughly 3 in in diameter as of Saturday Jan 30, increased to 4 1/2 in diameter by Monday am (feb 1). called physician's office and was advised to take ibuprofen every 6 hours until resolved, OTC hydrocortisone or diphenhydramine cream if itching was severe. Swelling and pain resolved in about 1 week with treatment.
Deep vein thrombosis; Pulmonary embolism; Shortness of breath; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEEP VEIN THROMBOSIS (Deep vein thrombosis) and PULMONARY EMBOLISM (Pulmonary embolism) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 012220A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 03-Jan-2021. Concomitant products included PARACETAMOL (TYLENOL), MAGNESIUM and VITAMIN B3 for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DEEP VEIN THROMBOSIS (Deep vein thrombosis) (seriousness criterion hospitalization) and PULMONARY EMBOLISM (Pulmonary embolism) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). The patient was hospitalized for 2 days due to DEEP VEIN THROMBOSIS and PULMONARY EMBOLISM. At the time of the report, DEEP VEIN THROMBOSIS (Deep vein thrombosis) and PULMONARY EMBOLISM (Pulmonary embolism) outcome was unknown and DYSPNOEA (Shortness of breath) had not resolved. Not Provided          The patient received Xarelto and IV blood thinner at hospital.  Company comment: Based on the information provided which includes a temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-083811 (Patient Link).; Sender's Comments: Based on the information provided which includes a temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded
Patient missed 15-18 month vaccine. trying to catch up vaccine. gave kinrix. that is not indicated till 4 yrs.
Got at the mass vaccination site, is a drive through site.  Husband was driving. Pt herself was in passenger seat  Reports she had her first covid vaccine 2/14/21 (pfizer) around 10;30am  Placed in left upper arm  about 10 min after the injection  + pain at the site, and then felt tight in shoulder  Then became nausea and her husband woke her up; and was about 15 seconds per her husbands report  No seizure activity  No rashes  No throat swelling  No swelling  No n/v  The vaccine staff then came over to her parked car  Took her BP and reports was low, cannot recall how low  Was starting to feel okay when the vaccine staff came over, reports was a national guard MD, who said he advised an epi pen due to her reaction, then to call 911.  And then was given epinephrine and then called the ambulance  Pt was feeling better when the EMT arrived, and was taken into the ambulance, she declined the ER   Went home, husband drove home, and she rested on the couch the rest of the afternoon  Has been feeling fine every since  Feels well, eating drinking like normal, no syncope, no rash, no changes to skin, no arm pain
This spontaneous report was received from a pharmacist and refers to a patient of unknown age. The patient's concomitant medication, pertinent medical history, drug reactions and allergies were not provided. On 01-DEC-2017, the patient was vaccinated with expired ZOSTAVAX vial 19400PFU, lot # M042504; expiry date 30-NOV-2017 (dose and route of administration were not provided) reconstituted with properly stored sterile diluent. No adverse effect were reported.
Information has been received from a medical assistant concerning a 24 year old female with no relevant medical history or allergies who on 18-JUN-2008 was vaccinated with a first dose of GARDASIL (lot number 659964/1978U) 0.5 ml by intramuscular injection into the left deltoid.  There was no concomitant medication.  On 19-JUN-2008 the patient developed local injection site reaction.  The injection site was red, itchy and swollen.  The patient said it looked like a "Cheetos chip" was inside the arm.  The patient sought unspecified medical attention.  At the time of reporting, the patient's events were recovering.  Follow-up information was received which reported that on 25-JUN-2008, the patient was recovered from all the events.  Additional information is not expected.